BridgeMD
Compares treatment options for Psoriasis
Official title Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction
ClinicalTrials.gov ID: NCT07183423
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if a novel barrier topical product works to treat barrier dysfunction in adults. It will also learn about the safety of the novel barrier topical product.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Clinical diagnosis of mild skin barrier dysfunction, including:
- Mild to moderate atopic dermatitis, defined as SCORAD ≤ 50, and/or not currently requiring topical corticosteroids or immunomodulators.
- Mild to moderate chronic plaque psoriasis, defined as total body surface area (BSA) involved: ≤3% to 10%.
- Contact dermatitis
- Seasonal xerosis or clinically evident skin dryness
You likely can't join if
- Failure to meet any of the above inclusion criteria
- Severe atopic dermatitis or psoriasis requiring systemic or high-potency topical treatment
- Use of corticosteroids, calcineurin inhibitors, biologics, or phototherapy within 2 weeks
- Open wounds or evidence of secondary infection at test sites
- Pregnant or breastfeeding women
- Multiple nevi, tattoos, dense body hair in the test areas
See the full eligibility criteria
- Clinical diagnosis of mild skin barrier dysfunction, including:
- Mild to moderate atopic dermatitis, defined as SCORAD ≤ 50, and/or not currently requiring topical corticosteroids or immunomodulators.
- Mild to moderate chronic plaque psoriasis, defined as total body surface area (BSA) involved: ≤3% to 10%.
- Contact dermatitis
- Seasonal xerosis or clinically evident skin dryness
- Symmetrical or bilateral test areas available (volar forearm)
- Willing and able to provide informed consent and adhere to study procedures
- Failure to meet any of the above inclusion criteria
- Severe atopic dermatitis or psoriasis requiring systemic or high-potency topical treatment
- Use of corticosteroids, calcineurin inhibitors, biologics, or phototherapy within 2 weeks
- Open wounds or evidence of secondary infection at test sites
- Pregnant or breastfeeding women
- Multiple nevi, tattoos, dense body hair in the test areas
- Debilitated or immunocompromised people
- Known or suspected hypersensitivity to the treatment product (or its ingredients) or petrolatum
- Refusal or failure to comply with the schedule of visits at the test site.
The study team makes the final eligibility decision.
Where it's taking place
- Makati City, National Capital Region, Philippines
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Makati City, National Capital Region, Philippines. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.